Diabetic Macular Edema (DME) Completed Phase 3 Trials for Ruboxistaurin (DB11829)

Also known as: Diabetic Macular Edema / Macular Edema, Diabetic / Diabetic Macular Oedema / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00133952Effect of Ruboxistaurin on Clinically Significant Macular EdemaTreatment